Metlife is one of the largest financial services companies in the U.S., and the largest U.S. life insurer. Longer-term, Metlife benefits from a strong global brand, a solid financial balance sheet and a large distribution network. From a macro perspective, rising interest rates and an easing of the regulatory environment should help push MET shares higher over the medium term. In November, MET announced a shareholder-friendly $3 billion share repurchase program that aims to be completed by the end of this year. Metlife shares appear undervalued – currently trading at a forward price-earnings multiple of 10x and a price-to-book ratio of 0.80x, a discount to its peer group on both metrics. In addition, MET shares currently pay an attractive 2.9 per cent dividend yield (which is expected to grow by about 10 per cent per year over the next few years).